市場調査レポート
商品コード
1284871

ライブセルイメージングの世界市場:製品・サービス別 (装置、消耗品、ソフトウェア、サービス)・用途別 (細胞生物学、幹細胞、創薬)・技術別 (タイムラプス顕微鏡、FRET、FRAP、HCS)・エンドユーザー別 (製薬・バイオテクノロジー企業、CRO) の将来予測 (2028年まで)

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2028

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 293 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.45円
ライブセルイメージングの世界市場:製品・サービス別 (装置、消耗品、ソフトウェア、サービス)・用途別 (細胞生物学、幹細胞、創薬)・技術別 (タイムラプス顕微鏡、FRET、FRAP、HCS)・エンドユーザー別 (製薬・バイオテクノロジー企業、CRO) の将来予測 (2028年まで)
出版日: 2023年05月30日
発行: MarketsandMarkets
ページ情報: 英文 293 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のライブセルイメージングの市場規模は、2023年の27億米ドルから、2028年には43億米ドルに達し、予測期間中 (2023年~2028年) に10.2%のCAGRで成長すると予測されています。

この市場の成長は、創薬におけるハイコンテントスクリーニング (HCS) 技術の採用が高い/伸びていることに起因していると考えられます。創薬においてハイスループットスクリーニングやHCS技術への依存度が高まるにつれ、ライブセルイメージング技術への需要が高まることが予想されます。この傾向は、ライブセルイメージングによって個々の患者に合った動向を明らかにする個別化医療分野で特に顕著になると予想されます。

"予測期間中の製品・サービス別シェアは、消耗品分野が2位"

世界のライブセルイメージング市場では2022年に、製品・サービス別で消耗品分野が2番目に大きなシェアを占めています。消耗品には、ライブセルイメージング・分析に使用されるさまざまな製品が含まれます。これらの消耗品は、サンプル調製、メンテナンス、分析に不可欠であるため、ライブセルイメージングのワークフローにおいて重要な役割を担っています。ライブセルイメージングに使用される消耗品には、試薬、培地、アッセイキット、その他マイクロプレート、スライド、ペトリ皿、カバースリップ、培養チャンバーなどの消耗品があります。消耗品は一般的に使い捨てで、定期的に補充する必要があるため、メーカーにとって重要な経常収益の柱となっています。消耗品はライブセルイメージングに不可欠な要素であり、この分野の成長は、主に高度なイメージング技術への需要の高まりと、さまざまな研究用途におけるライブセル解析の採用拡大によってもたらされます。

"欧州:ライブセルイメージング市場において2番目に大きな地域"

欧州は北米に次いで、世界で2番目に大きなライブセルイメージング市場となっています。欧州のライブセルイメージング市場は、その拡大を後押しする様々な要因によって、近年著しい成長を遂げています。欧州は、ライブセルイメージング分野における新技術の開発・導入の最前線にあります。これには、超解像顕微鏡、ハイスループットイメージング、シングルセルイメージング、マルチモーダルイメージングアプローチの進歩が含まれます。これらの革新的な技術の採用は、ライブセルイメージング研究の進展を加速させ、その応用を拡大させます。さらに、欧州ではライブセルイメージング技術に関する包括的なトレーニングや教育プログラムが提供されています。大学や研究機関、団体が、科学者や研究者の知識や技術を向上させるための専門コースやワークショップ、会議を開催しています。トレーニングプログラムの充実は、欧州におけるライブセルイメージング技術の導入と活用を促進します。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 技術分析
  • 顧客のビジネスに影響を与える動向/混乱
  • バリューチェーン/サプライチェーン分析
  • 規制分析
  • ポーターのファイブフォース分析
  • エコシステム分析
  • 価格分析
  • 主な会議とイベント (2022年~2023年)
  • 主要な利害関係者と購入基準
  • 特許分析

第6章 ライブセルイメージング市場:製品・サービス別

  • イントロダクション
  • 装置
    • 顕微鏡
    • スタンドアロン型システム
    • 細胞分析装置
    • 付属品
  • 消耗品
    • 試薬
    • アッセイキット
    • メディア
    • その他の消耗品
  • ソフトウェア
  • サービス

第7章 ライブセルイメージング市場:用途別

  • イントロダクション
  • 細胞生物学
  • 幹細胞
  • 発生生物学
  • 創薬

第8章 ライブセルイメージング市場:技術別

  • イントロダクション
  • タイムラプス顕微鏡
  • FRET (蛍光共鳴エネルギー移動)
  • FRAP (光退色後の蛍光回復)
  • HCS (ハイコンテンツスクリーニング)
  • その他の技術

第9章 ライブセルイメージング市場:エンドユーザー別

  • イントロダクション
  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • CRO (医薬品開発業務受託機関)

第10章 ライブセルイメージング市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • イントロダクション
  • 主要企業が採用した戦略
  • 収益シェア分析
  • 市場シェア分析
  • 企業評価クアドラント:主要企業
  • 上位25社の競合ベンチマーキング
  • 企業評価クアドラント:スタートアップ/中小企業
  • スタートアップ/中小企業の競合ベンチマーキング
  • 競合シナリオと動向

第12章 企業プロファイル

  • 主要企業
    • DANAHER
    • ZEISS GROUP
    • SARTORIUS AG
    • THERMO FISHER SCIENTIFIC, INC.
    • OLYMPUS CORPORATION
    • PERKINELMER INC.
    • NIKON CORPORATION
    • ETALUMA, INC.
    • CYTOSMART TECHNOLOGIES
    • AGILENT TECHNOLOGIES, INC.
    • NANOENTEK INC.
    • BECTON, DICKINSON AND COMPANY
    • GE HEALTHCARE
    • BRUKER CORPORATION
    • MERCK KGAA
    • BIO-RAD LABORATORIES, INC.
    • CORNING INCORPORATED
  • その他の企業
    • BLUE-RAY BIOTECH CORP.
    • CYTENA GMBH
    • NANOLIVE SA
    • ABBERIOR
    • PHASE HOLOGRAPHIC IMAGING PHI AB
    • CYTOSKELETON, INC.
    • KEYENCE CORPORATION
    • ALIGNED GENETICS, INC.

第13章 付録

目次
Product Code: BT 3390

The global live cell imaging market is projected to reach USD 4.3 billion by 2028 from USD 2.7 billion in 2023, at a CAGR of 10.2% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the high/growing adoption of high-content screening techniques in drug discovery. As drug discovery becomes increasingly reliant on high-throughput screening and HCS techniques, the demand for live cell imaging technology is likely to grow. This trend is expected to be particularly pronounced in the field of personalized medicine, where live cell imaging can be used to identify treatments tailored to individual patients.

"The consumables segment accounted for the second-largest share by product & service during the forecast period"

In 2022, consumables segment accounted for the second-largest share by product & service in the global live cell imaging market. Consumables include a range of products that are used in the imaging and analysis of live cells. These consumables play an important role in the live cell imaging workflow, as they are essential for sample preparation, maintenance, and analysis. Consumables used in live cell imaging include reagents, media, assay kits, and other consumables such as microplates, slides, Petri dishes, coverslips, and culture chambers. Consumables are typically disposable and need to be replenished regularly, making them an important recurring revenue stream for manufacturers. Consumables are an integral part of live cell imaging, and growth in this segment is mainly driven by the increasing demand for advanced imaging technologies and the growing adoption of live cell analysis in various research applications.

"Europe: The second largest region in the live cell imaging market"

Europe accounted for the second-largest market for live cell imaging after North America. The European live cell imaging market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. Europe is at the forefront of developing and adopting emerging technologies in the field of live cell imaging. This includes advancements in super-resolution microscopy, high-throughput imaging, single-cell imaging, and multi-modal imaging approaches. The adoption of these innovative technologies accelerates the progress of live cell imaging research and expands its applications. Additionally, Europe offers comprehensive training and education programs in live cell imaging techniques. Universities, research institutes, and organizations provide specialized courses, workshops, and conferences to enhance the knowledge and skills of scientists and researchers. The availability of training programs promotes the adoption and utilization of live cell imaging technologies in Europe.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80% and Demand Side 20%
  • By Designation: C-level - 45%, D-level - 30%, and Others - 25%
  • By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%

List of Companies Profiled in the Report:

  • Danaher (US)
  • ZEISS Group (Germany)
  • Nikon Corporation (Japan)
  • Olympus Corporation (Japan)
  • PerkinElmer Inc. (US)
  • Sartorius AG (Germany)
  • Agilent Technologies, Inc. (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Etaluma, Inc. (US)
  • CytoSMART Technologies (Netherlands)
  • NanoEnTek Inc. (South Korea)
  • GE Healthcare (US)
  • Bruker Corporation (US)
  • Becton, Dickinson and Company (BD) (US)
  • Merck KGaA (Germany)
  • Bio-Rad Laboratories, Inc. (US)
  • Blue-Ray Biotech Corp. (Taiwan)
  • CYTENA GmbH (Germany)
  • Nanolive SA (Switzerland)
  • Abberior (Germany)
  • Phase Holographic Imaging (PHI) AB (Sweden)
  • Cytoskeleton, Inc. (US)
  • Corning Incorporated (US)
  • KEYENCE Corporation (Japan)
  • Aligned Genetics, Inc. (South Korea)

Research Coverage:

This report provides a detailed picture of the live cell imaging market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, application, technology, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges

The report provides insights on the following pointers:

  • Analysis of key drivers (growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and growing availability of funds for research), restraints (High cost of high-content screening systems), opportunities (increasing adoption of live cell imaging technologies in emerging markets, and application of HCS in personalized medicine), and challenges (maintaining cell viability and cellular environment in cell cultures, and image analysis and data management) influencing the growth of the market.
  • Product and Service Development/Innovation: Detailed insights on newly launched products & services, and technological assessment of the live cell imaging market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the live cell imaging market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and products and service offerings of leading players like Danaher (US), ZEISS Group (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (South Korea), GE Healthcare (US), Bruker Corporation (US), Becton, Dickinson and Company (BD) (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Blue-Ray Biotech Corp. (Taiwan), CYTENA GmbH (Germany), Nanolive SA (Switzerland), Abberior (Germany), Phase Holographic Imaging (PHI) AB (Sweden), Cytoskeleton, Inc. (US), Corning Incorporated (US), KEYENCE Corporation (Japan), Aligned Genetics, Inc. (South Korea), and among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
    • FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
    • FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2022
    • 2.2.1 INSIGHTS FROM PRIMARIES
    • FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
    • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.3 GROWTH FORECAST
    • FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2022-2028
    • FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 RECESSION IMPACT ON LIVE CELL IMAGING MARKET
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)
    • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 12 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF LIVE CELL IMAGING MARKET

4 PREMIUM INSIGHTS

  • 4.1 LIVE CELL IMAGING MARKET OVERVIEW
    • FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022)
    • FIGURE 18 INSTRUMENTS DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2022
  • 4.3 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 19 INSTRUMENTS TO CONTINUE TO DOMINATE MARKET BY 2028
  • 4.4 LIVE CELL IMAGING MARKET SHARE, BY END USER, 2022
    • FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN LIVE CELL IMAGING MARKET FROM 2023 TO 2028

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing adoption of high-content screening techniques in drug discovery
      • 5.2.1.2 Rising incidence of cancer
    • TABLE 5 ESTIMATED NEW CANCER CASES IN US, 2023
    • FIGURE 23 GLOBAL CANCER INCIDENCE & MORTALITY, 2020
      • 5.2.1.3 Growing availability of research funds
    • TABLE 6 INVESTMENT BREAKDOWN, 2021 (USD MILLION)
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of high-content screening systems
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing adoption of live cell imaging technologies in emerging economies
      • 5.2.3.2 Applications of HCS in personalized medicine
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Maintaining cell viability and cellular environment in cell cultures
      • 5.2.4.2 Image analysis and data management
  • 5.3 TECHNOLOGY ANALYSIS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR LIVE CELL IMAGING PRODUCT & SERVICE PROVIDERS
  • 5.5 VALUE/SUPPLY CHAIN ANALYSIS
    • 5.5.1 VALUE CHAIN ANALYSIS
    • FIGURE 25 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS
    • 5.5.2 SUPPLY CHAIN ANALYSIS
    • FIGURE 26 LIVE CELL IMAGING MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 REGULATORY ANALYSIS
    • 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.6.1.1 North America
        • 5.6.1.1.1 US
        • 5.6.1.1.2 Canada
      • 5.6.1.2 Europe
      • 5.6.1.3 Asia Pacific
      • 5.6.1.4 Rest of the World
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 LIVE CELL IMAGING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 ECOSYSTEM ANALYSIS
    • TABLE 8 SUPPLY CHAIN ECOSYSTEM
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER
    • TABLE 9 AVERAGE SELLING PRICES
    • 5.9.2 AVERAGE SELLING PRICE TREND
  • 5.10 KEY CONFERENCES & EVENTS IN 2022-2023
    • TABLE 10 LIVE CELL IMAGING: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LIVE CELL IMAGING PRODUCTS
    • 5.11.2 BUYING CRITERIA FOR LIVE CELL IMAGING
    • FIGURE 28 KEY BUYING CRITERIA FOR END USERS
  • 5.12 PATENT ANALYSIS
    • FIGURE 29 LIVE CELL IMAGING MARKET: PATENT APPLICATIONS (JANUARY 2020-APRIL 2023)

6 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 11 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • 6.2 INSTRUMENTS
    • TABLE 12 EXAMPLES OF INSTRUMENTS OFFERED BY MARKET PLAYERS
    • TABLE 13 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 14 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 15 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 16 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.1 MICROSCOPES
      • 6.2.1.1 Continuous technological advancements in microscopes to support market
    • TABLE 19 CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
    • TABLE 20 CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS
    • TABLE 21 FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS
    • TABLE 22 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 23 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 26 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.2 STANDALONE SYSTEMS
      • 6.2.2.1 Seamless integration and workflow efficiency of standalone systems to boost demand
    • TABLE 27 STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS
    • TABLE 28 LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 29 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 31 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 32 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 CELL ANALYZERS
      • 6.2.3.1 Accuracy and reproducibility of cell analyzers to support growth
    • TABLE 33 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS
    • TABLE 34 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 35 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.4 ACCESSORIES
      • 6.2.4.1 Ability of accessories to optimize and enhance imaging conditions to boost demand
    • TABLE 39 ACCESSORIES OFFERED BY KEY MARKET PLAYERS
    • TABLE 40 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 41 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 CONSUMABLES
    • TABLE 45 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 46 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.1 REAGENTS
      • 6.3.1.1 Widespread usage in life science research to fuel market growth
    • TABLE 51 REAGENTS OFFERED BY KEY MARKET PLAYERS
    • TABLE 52 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 53 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 56 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.2 ASSAY KITS
      • 6.3.2.1 Repeat purchase of assay kits to drive market
    • TABLE 57 ASSAY KITS OFFERED BY KEY MARKET PLAYERS
    • TABLE 58 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 59 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 62 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 MEDIA
      • 6.3.3.1 Increasing demand for optimized cell culture conditions to drive demand for media
    • TABLE 63 MEDIA OFFERED BY KEY MARKET PLAYERS
    • TABLE 64 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 65 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 68 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.4 OTHER CONSUMABLES
    • TABLE 69 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS
    • TABLE 70 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 71 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 72 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 73 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 SOFTWARE
    • 6.4.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION TO BOOST MARKET GROWTH
    • TABLE 75 SOFTWARE OFFERED BY KEY MARKET PLAYERS
    • TABLE 76 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 77 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 78 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.5 SERVICES
    • 6.5.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO SUPPORT MARKET
    • TABLE 81 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 82 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 83 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 85 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 LIVE CELL IMAGING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 86 LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 7.2 CELL BIOLOGY
    • TABLE 87 NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040
    • TABLE 88 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 89 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 90 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 91 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 STEM CELLS
    • 7.3.1 GROWING FOCUS ON REGENERATIVE MEDICINE & ADVANCEMENTS IN STEM CELL RESEARCH TO BOOST MARKET
    • TABLE 93 LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 94 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 95 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 97 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 DEVELOPMENTAL BIOLOGY
    • 7.4.1 GROWING INTEREST IN UNDERSTANDING ORGANOGENESIS AND TISSUE MORPHOGENESIS TO DRIVE DEMAND
    • TABLE 98 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 99 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 100 EUROPE: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 102 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 DRUG DISCOVERY
    • 7.5.1 GROWING USE OF HCS CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO DRIVE DEMAND
    • TABLE 103 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 104 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 105 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

8 LIVE CELL IMAGING MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
    • TABLE 108 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 8.2 TIME-LAPSE MICROSCOPY
    • TABLE 109 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 110 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 111 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 113 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET)
    • 8.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST ADOPTION OF FRET TECHNOLOGY
    • TABLE 114 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 115 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 116 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 118 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP)
    • 8.4.1 INTEGRATION OF FRAP WITH LIVE CELL IMAGING MICROSCOPY TO CONTRIBUTE TO MARKET GROWTH
    • TABLE 119 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 120 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 121 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 123 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 HIGH-CONTENT SCREENING (HCS)
    • 8.5.1 GROWING ADOPTION OF HCS IN DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE GROWTH
    • TABLE 124 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 125 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 126 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 128 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.6 OTHER TECHNOLOGIES
    • TABLE 129 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 130 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 131 EUROPE: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 133 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)

9 LIVE CELL IMAGING MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 134 LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 NEED TO ADHERE TO STRICT REGULATIONS TO DRIVE USE OF LIVE CELL IMAGING PRODUCTS AMONG PHARMA COMPANIES
    • TABLE 135 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 136 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 137 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 139 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 ACADEMIC & RESEARCH INSTITUTES
    • 9.3.1 INCREASING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH
    • TABLE 140 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 141 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 142 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 143 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 144 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 CONTRACT RESEARCH ORGANIZATIONS
    • 9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE DEMAND
    • TABLE 145 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 146 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 147 EUROPE: LIVE CELL IMAGING MARKET FOR F CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 148 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 149 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

10 LIVE CELL IMAGING MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 150 LIVE CELL IMAGING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT
    • TABLE 151 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 152 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 153 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 154 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 156 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 157 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 US to dominate live cell imaging market in North America
    • TABLE 158 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 159 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 162 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 163 US: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Government initiatives to promote research to support market growth
    • TABLE 164 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 165 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 166 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 167 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 168 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 169 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    • TABLE 170 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 171 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 172 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 173 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 174 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 175 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 176 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Presence of large number of academic research institutes to boost market
    • TABLE 177 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 178 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 179 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 180 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 181 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 182 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Investments by pharmaceutical sponsors for drug discovery services to support market
    • FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011-2020 (USD MILLION)
    • TABLE 183 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 184 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 185 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 186 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 187 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 188 UK: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Large pharmaceutical manufacturing industry to drive market growth
    • TABLE 189 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 190 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 191 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 192 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 193 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 194 FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Strong research tradition, government funding, and collaborative research networks to fuel growth
    • TABLE 195 ITALY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 196 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 197 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 198 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 199 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 200 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Rising R&D expenditure to boost market
    • TABLE 201 SPAIN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 202 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 203 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 204 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 205 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 206 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 207 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 208 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 209 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 210 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 211 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 212 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 EUROPE: RECESSION IMPACT
  • 10.4 ASIA PACIFIC
    • TABLE 213 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 214 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 215 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 216 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 217 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 218 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 219 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 China to dominate APAC live cell imaging market
    • TABLE 220 CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 221 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 222 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 223 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 224 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 225 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising prominence of regenerative medicine research to drive market growth
    • TABLE 226 JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 227 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 228 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 229 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 230 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 231 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Growing pharmaceutical industry to create favorable opportunities for market players
    • TABLE 232 INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 233 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 234 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 235 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 236 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 237 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC (ROAPAC)
    • TABLE 238 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 239 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 240 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 241 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 242 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 243 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 ASIA PACIFIC: RECESSION IMPACT
  • 10.5 LATIN AMERICA
    • TABLE 244 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 245 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 246 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 247 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 248 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 249 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 250 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Gradual growth in research to contribute to growth
    • TABLE 251 BRAZIL: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 252 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 253 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 254 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 255 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 256 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 REST OF LATIN AMERICA
    • TABLE 257 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 258 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 259 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 260 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 261 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 262 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.3 LATIN AMERICA: RECESSION IMPACT
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH
    • TABLE 263 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 264 MIDDLE EAST & AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 265 MIDDLE EAST & AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 266 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 267 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 268 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 32 LIVE CELL IMAGING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 REVENUE SHARE ANALYSIS
    • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020-2022
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
    • TABLE 269 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS
    • FIGURE 35 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
  • 11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
    • 11.6.1 END-USER FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 270 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
    • 11.6.2 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 271 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
    • 11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 272 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET
  • 11.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • FIGURE 36 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 STARTING BLOCKS
    • 11.7.3 RESPONSIVE COMPANIES
    • 11.7.4 DYNAMIC COMPANIES
  • 11.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
    • TABLE 273 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
    • TABLE 274 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
  • 11.9 COMPETITIVE SCENARIO AND TRENDS
    • 11.9.1 PRODUCT LAUNCHES
    • TABLE 275 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020-DECEMBER 2022
    • 11.9.2 DEALS
    • TABLE 276 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2020-DECEMBER 2022
    • 11.9.3 OTHER DEVELOPMENTS
    • TABLE 277 LIVE CELL IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2020-DECEMBER 2022

12 COMPANY PROFILES

  • 12.1 KEY COMPANIES
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 DANAHER
    • TABLE 278 DANAHER: BUSINESS OVERVIEW
    • FIGURE 37 DANAHER: COMPANY SNAPSHOT (2022)
    • 12.1.2 ZEISS GROUP
    • TABLE 279 ZEISS GROUP: BUSINESS OVERVIEW
    • FIGURE 38 ZEISS GROUP: COMPANY SNAPSHOT (2022)
    • 12.1.3 SARTORIUS AG
    • TABLE 280 SARTORIUS AG: BUSINESS OVERVIEW
    • FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2022)
    • 12.1.4 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 281 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.5 OLYMPUS CORPORATION
    • TABLE 282 OLYMPUS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 41 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.6 PERKINELMER INC.
    • TABLE 283 PERKINELMER INC.: BUSINESS OVERVIEW
    • FIGURE 42 PERKINELMER INC.: COMPANY SNAPSHOT (2023)
    • 12.1.7 NIKON CORPORATION
    • TABLE 284 NIKON CORPORATION: BUSINESS OVERVIEW
    • FIGURE 43 NIKON CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.8 ETALUMA, INC.
    • TABLE 285 ETALUMA, INC.: BUSINESS OVERVIEW
    • 12.1.9 CYTOSMART TECHNOLOGIES
    • TABLE 286 CYTOSMART TECHNOLOGIES.: BUSINESS OVERVIEW
    • 12.1.10 AGILENT TECHNOLOGIES, INC.
    • TABLE 287 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.11 NANOENTEK INC.
    • 12.1.12 BECTON, DICKINSON AND COMPANY
    • TABLE 288 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • 12.1.13 GE HEALTHCARE
    • TABLE 289 GE HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 46 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
    • 12.1.14 BRUKER CORPORATION
    • TABLE 290 BRUKER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 47 BRUKER CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.15 MERCK KGAA
    • TABLE 291 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • 12.1.16 BIO-RAD LABORATORIES, INC.
    • TABLE 292 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 49 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.17 CORNING INCORPORATED
    • TABLE 293 CORNING INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
  • 12.2 OTHER PLAYERS
    • 12.2.1 BLUE-RAY BIOTECH CORP.
    • 12.2.2 CYTENA GMBH
    • 12.2.3 NANOLIVE SA
    • 12.2.4 ABBERIOR
    • 12.2.5 PHASE HOLOGRAPHIC IMAGING PHI AB
    • 12.2.6 CYTOSKELETON, INC.
    • 12.2.7 KEYENCE CORPORATION
    • 12.2.8 ALIGNED GENETICS, INC.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS